KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Please contact us if you have any questions about US Corporate Tax or on any other matter.
Wade Wagatsuma
Seconded Partner, International Corporate Tax Services (US)
+852 2685 7806
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.